Skip to content
Clinical Trials – home

Centrum Medyczne Lukamed Joanna Luka

Research site

Poland Adama Mickiewicza 39, 89-600 Chojnice, Poland

  • Chronic obstructive pulmonary disease · Colitis ulcerative
  • Adult patients

About Specializations

Centrum Medyczne Lukamed Joanna Luka in Chojnice, Poland specialises in clinical trials of conditions such as Chronic obstructive pulmonary disease, Colitis ulcerative, and other specialisations. This site conducts important research.

Main research areas of the site

Respiratory Tract Diseases

Centrum Medyczne Lukamed Joanna Luka is conducting research on Chronic Obstructive Pulmonary Disease to test a novel therapy aimed at lowering the frequency of moderate and severe flare‑ups over a year of treatment.

  • Evaluation of new biologic agents for COPD
  • Improving management of disease exacerbations
  • Assessing long‑term safety of emerging treatments

Participants benefit from comprehensive monitoring and support, which enhances understanding of sustained disease control.

Digestive System Diseases

The centre is also focused on Ulcerative Colitis, evaluating an investigational compound for its ability to induce clinical remission in individuals with active disease.

  • Clinical response to novel oral agents for ulcerative colitis
  • Optimizing induction therapy for moderate to severe disease
  • Safety monitoring of targeted immunomodulators

Study involvement includes regular assessments that help refine therapeutic strategies for patients with moderate to severe colitis.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Adama Mickiewicza 3989-600 ChojnicePoland
Recruiting now
no trials
Conditions studied
2

More sites in ChojnicePoland

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

2 clinical trials

Study of Astegolimab Treatment in Patients with Chronic Obstructive Pulmonary Disease (COPD) to Reduce Disease Flare-ups

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Astegolimab
  • Sponsor:F. Hoffmann-La Roche AG

Colitis ulcerative

Not recruiting

Study on the Effectiveness and Safety of JNJ-77242113 for Patients with Moderate to Severe Ulcerative Colitis

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Azathioprine
  • Sponsor:Janssen Cilag International
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.